Samjin succeeds in formulating clopidogrel in globule form

Published: 2009-03-25 06:58:00
Updated: 2009-03-25 06:58:00
Samjin Pharm announced it has started synthesizing clopidogrel bisulfate (hydrogen sulfate) in globulet form after the recent approval of the Ministry of Health, Welfare and Family Affairs.

The company is expected to ensure at least $10 million import substitution effect.

“The successful sy...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.